🇺🇸 FDA
Patent

US 11299512

Cyclic di-nucleotide compounds and methods of use

granted A61KA61K31/7084A61K45/06

Quick answer

US patent 11299512 (Cyclic di-nucleotide compounds and methods of use) held by The Board of Regents of the University of Texas System expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/7084, A61K45/06, A61P, A61P31/00